Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma.

ABSTRACT:

SUBMITTER: Liu J 

PROVIDER: S-EPMC7490411 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature